Drug Trial Radar · NCT06332092
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
46
Planned (sponsor's estimate)
Start
Apr 10, 2024
Primary completion
Dec 31, 2025
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Fulgent Pharma LLC.Industry
- Sponsor type
- Industry
- First posted
- Mar 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this FID-007 Clinical Trial is to compare the efficacy of different dosing regimens of FID-007 in combination with Cetuximab in patients with recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). The main questions it aims to answer are: to evaluate the efficacy, and to characterize the safety and tolerability. Eligible participants will be enrolled and randomized to 1 of 2 arms of FID-007 with fixed-dose Cetuximab in each 28-day cycle.
Conditions
- Head and Neck Squamous Cell Carcinoma
Interventions
FID007Drug
Patients will receive FID007 via IV infusion at their assigned dose on Days 1, 8, and 15 of each 28-day cycle. Starting from Cycle 2, Cetuximab will be administered every 2 weeks on Days 1 and 15 of each 28-day cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- ORR assessed by Response Evaluation Criteria in Solid Tumors (RECIST)Time frame: Through study completion, an average of 1 year
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Highlands Oncology - North Hills
Fayetteville, Arkansas
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California
Moffitt Cancer Center Magnolia Campus
Tampa, Florida
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas
Texas Oncology - Northeast Texas Cancer & Research Institute
Tyler, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.